Mesothelioma is a disease that affects the cells that line certain organs, called mesothelial cells. It's a rare type of cancer — only around 3,000 new cases are diagnosed in the United States each year. Source: American Society of Clinical Oncology
Mesothelioma occurs more often in men. The average age for a pleural mesothelioma diagnosis is 69.
Mesothelioma affects four regions of the body: the lungs, the abdominal region, the heart and the testicles.
Our team of specialists combines deep expertise and advanced technology to provide you with the most accurate diagnosis — leading to the most effective treatment. They may use one or a combination of tests to diagnose mesothelioma, depending on the area of the body affected.
We understand that you — and your specific type of mesothelioma — are unique, and we act on that knowledge to identify the right therapy for you.
Being diagnosed with mesothelioma can be frightening. Getting through it and figuring out how to live a long life takes layers of support.
City of Hope is home to world experts on mesothelioma. These professionals collaborate freely and work urgently to ensure that you get the highest caliber of care. In addition, we are a leader in precision medicine, evaluating the specific characteristics of the disease to pinpoint the best treatment options.
Our focus on translating science into patient care includes clinical trials to discover more effective drug combinations targeting mesothelioma cells. Here are some highlights of our program:
- Multidisciplinary care that includes input at all stages of your treatment.
- For pleural mesothelioma, lung experts who regularly treat aggressive and late-stage cancer, including complicated cases other institutions may have deemed untreatable.
- Minimally invasive techniques, including laparoscopic and robotic surgery that minimize harm to the body and speed up recovery.
- Compassionate care from staff who listens and communicates openly to patient and family concerns.
- Exceptional family and survivorship programs.
When we treat cancer at City of Hope, we don't just focus on high-quality care and innovation — we are working to make you whole again.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Arya Amini, M.D., is a radiation oncologist and associate professor in the Department of Radiation Oncology at City of Hope.
Jae Y. Kim, M.D., is the chief of the Division of Thoracic Surgery and an associate professor in the Department of Surgery. Dr. Kim specializes in esophageal cancer and lung cancer, robotic surgery, mesothelioma and thymoma.
Erminia Massarelli, M.D., Ph.D., M.S., is the co-director of the Lung Cancer and Thoracic Oncology Program, and an associate professor in the Department of Medical Oncology & Therapeutics Research at City of Hope. She specializes in lung and head and neck cancers.
Dan Raz, M.D., M.A.S., is co-director of the Lung Cancer and Thoracic Oncology Program and an associate professor in the Division of Thoracic Surgery. Dr. Raz specializes in esophageal and lung cancer surgery – and in raising public awareness about cancer risks.
Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Chair in Medical Oncology at City of Hope and an expert in the study and treatment of lung cancer, mesothelioma, thoracic and thymic malignancies and bronchial carcinoids.
Sagus Sampath, M.D., Radiation Oncologist | City of Hope, Los Angeles, CA